Adial Pharmaceuticals Inc – Filings and Transcripts

NASDAQ: ADIL
Share price (7/22/26): $2.70
Market cap (7/22/26): $5.788 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Exempt offering of securities

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Coastlands Capital LP

Coastlands Capital LP

Coastlands Capital LP

Coastlands Capital LP

Coastlands Capital LP

News Filter

Announces Acquisition of Azora Therapeutics and Up to $64 Million Financing

Reports 2026 First Quarter Financial Results and Provides Business Update

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Reports 2025 Fiscal Year Financial Results and Provides Business Update

Signs an Exclusive AD04 Collaboration Framework With Molteni Farmaceutici for Europe Which Anticipates Nearly $60 Million in Potential Royalties and Milestones Upon Execution of a Definitive Agreement

Proxies Filter

Definitive proxy

Preliminary proxy

Preliminary revised proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC